Updates to the Appropriate-Use Criteria for Somatostatin Receptor PET
Thomas A. Hope
Abstract
The guidelines of the Centers for Medicare and Medicaid Services require that appropriate-use criteria (AUC) be reviewed yearly. The somatostatin receptor (SSTR) PET AUC was originally approved in 2017 ([1][1]). There were no significant updates in the first 2 annual reviews, but this year there are
Topics & Concepts
MedicaidSomatostatin receptorSomatostatinMedicineMedical physicsInternal medicinePolitical scienceHealth careLawNeuroendocrine Tumor Research AdvancesLung Cancer Research StudiesNeuroblastoma Research and Treatments